Jessica's Press Releases

Wednesday, September 12, 2018

Trepp Launches CECL Benchmarks Tool to Help Banks Strengthen CECL Analysis

Trepp, LLC, the leading provider of information, analytics, and technology to the structured finance, commercial real estate, and banking markets, announced today it has launched CECL (Current Expected Credit Loss) Benchmarks™, a solution designed to bridge the gap for banks in search of data to estimate and justify their reserves under CECL.

"The breadth and depth of data required to estimate and justify reserves under CECL are much greater than what most banks have available," said Russell Hughes, Trepp VP and Banking Product Manager. "Trepp has stepped up to deliver CECL Benchmarks™, a CRE data solution that provides customers with easy access to 20+ years of historical data from the highest quality CRE loan data set available."

Built from Trepp's CMBS data feed – the de facto gold standard in quality for CRE loan data – Benchmarks™ allows users to leverage data to establish loss rates for mean reversion, validate model output or justify qualitative adjustment. With a user-friendly and intuitive interface, banks can quickly sort, aggregate, view, and download historical lifetime loss rates for CRE loans across a range of loan attributes and credit profiles. Users can easily export the results into Excel for integration with their broader CECL process.

"This tool is extremely valuable to institutions with limited internal loan loss data to effectively perform CECL analysis," Hughes added. "Benchmarks™' seamless interface eliminates the need for data scientists to slice and dice large data sets. Instead, this product allows them to spend their time doing what really matters: finding where their portfolio outperforms and underperforms benchmarks."

Trepp CECL Benchmarks™ is a data module delivered through the Trepp Default Model™, a web-based platform that enables banks to forecast commercial real estate loan Probability of Default (PD), Loss Given Default LGD), and Expected Loss (EL) at the loan and portfolio levels. For more information on Trepp CECL Benchmarks, visit our website: https://www.trepp.com/products/bank/trepp-cecl-benchmarks.

About Trepp
Trepp, LLC, founded in 1979, is the leading provider of information, analytics and technology to the CMBS, commercial real estate and banking markets. Trepp provides primary and secondary market participants with the web-based tools and insight they need to increase their operational efficiencies, information transparency and investment performance. From its offices in New York, San Francisco and London, Trepp serves its clients with products and services to support trading, research, risk management, surveillance and portfolio management. Trepp is wholly-owned by Daily Mail and General Trust (DMGT). For more information, visit http://www.Trepp.com.

All information are taken from the news source. We do not promise anything nor take any responsibility for anything the news owner claim. We just share the news as is. You can contact news owner directly in the message for more information.

Captivating Novel and 2018 Next Generation Indie Book Awards Finalist ‘The Funeral Plain’ is Released

Author Michael Dean Kiggans has debuted his first fiction book, "The Funeral Plain," which chronicles a young man's journey to finding the truth of life after tragedy strikes. An iUniverse Editor's Choice book and a 2018 Next Generation Indie Book Awards finalist in two categories for First Novel and General Fiction/Novel under 80,000 words, "The Funeral Plain" has been receiving rave reviews for its realistic characters and fascinating page-turning story.

In this coming of age roman á clef set in Ohio, protagonist Elijah Rake recalls the fateful day his father suddenly died in a skydiving plane crash when he was only nine years old. Through vivid memories, he recounts the effect of not having a father in his life had on his childhood and family as he comes to accept that death is inevitable. After much reflection and reconciliation, Elijah is able to grow into the man he becomes at the end of the story.

"I wanted to write a 'literary thriller' for people who love great stories," said Kiggans. "But I wanted it to represent real life, because we don't always get a happy ending in real life. The book has ties to something similar that happened in my family over 50 years ago. Much like Elijah, I was able to create a legendary story from this experience."

"The Funeral Plain" highlights themes of personal development, life, death, family and relationships as it reminds readers that before death, there is a rich life worth discovering and living.

The book has already entertained and touched readers with one reader calling it "…a nice piece of work. You should be proud…a melancholy delight." Another wrote, "Just finished reading it cover to cover, could not put it down."

"The Funeral Plain is an incredibly well written and absorbing novel that so easily captures the reader that it's hard to believe it's Mr. Kiggans' first book. This gentleman is an exceptionally talented writer and I highly recommend this novel." – Amazon reviewer

"The Funeral Plain"
By Michael Dean Kiggans
ISBN: 978-1-5320-20582-1 (SC); 978-1-5320-20575-1 (EB)
Available at the iUniverse Online Bookstore, Amazon, and Barnes & Noble

About the author
Michael Dean Kiggans is an avid reader and collector of fine books and literature. He currently resides near New Matamoras, Ohio, with his wife, Deborah. "The Funeral Plain" is his first novel which was honored as an iUniverse Editor's Choice book and was recently a finalist in two categories for the 2018 Next Generation Indie Book Awards.

Review Copies & Interview Requests:
LAVIDGE – Phoenix
Lauren Dickerson
480-306-7117
ldickerson(at)lavidge.com

Tuesday, September 11, 2018

Big Data Infrastructure Automation Provider Gemini Data Awards Public Sector Partner, Epoch Concepts, with Premier Status

Gemini Data Inc, a provider of the leading big data infrastructure platform, Gemini Enterprise, today announced Epoch Concepts LLC has achieved Premier Partner Status. A key component of Gemini Data's public sector strategy is to engage with partners that understand the power of combining existing data platform technologies with advanced processes like automation, machine learning, and automatic data discovery to drive greater value and efficiency in their client's big data and security technology stack. Epoch Concepts delivers on this objective while providing unparalleled customer service and support.

Gemini Data's Public Sector Director, Andrew Hooson, recognizes "Epoch Concepts has demonstrated the ability to truly understand their customers' big data vision and help them realize significant efficiencies using leading edge solutions. I'm excited that we have established such a strong partnership and look forward to working with the team to solve our customer's big data challenges, including reducing platform costs."

Gemini Data's platform is used globally to bring the vision of big data into reality by automating the management of data platforms and unlocking valuable intelligence from IT data. By automating data infrastructure and analysis and offering an on-prem, cloud, or hybrid solution, Gemini provides a full stack solution that holistically addresses security and privacy concerns.

"Gemini Data is one of those complementary technologies that aligns perfectly with our company mission. Creating purpose-built solutions that incorporate efficiencies like automation and machine learning mean our customers can spend more time on mission and less time worrying about the low value issues & bottlenecks that come from old outdated IT platforms. We are proud of the recognition from Gemini Data and look forward to continuing this partnership." Said Kevin Mackey, Epoch Concept's Chief Revenue Officer.

About Gemini Data

Gemini Data automates data infrastructure and analysis across silos to unleash the potential of big data investments. The Gemini Enterprise platform provides the fastest path to extracting value from machine data. Designed for modern architectures needing to reduce complexity, the solution is delivered on-prem, in the cloud, or as a hybrid option. Gemini Data is lead by experts from technology heavyweights such as Splunk, AppDynamics, and ArcSight. Find more information at geminidata.com or follow us on Twitter @geminidataco.

About Epoch Concepts, LLC.

Epoch Concepts LLC, a Service Disabled Veteran Owned Small Business (SDVOSB) located in Highlands Ranch, CO and Albuquerque, NM, is dedicated to providing best of breed technologies and services to both government and enterprise customers. The firm offers a full suite of products as well as pre-staging to easy delivery and implementation. Epoch enables customers to protect and evolve their enterprise through innovative best of breed products, from end point to data, and everything in between. They hold contracts with SEWP, GSA, and DISA.

Former Citigroup Veterans Launch Innovative Investment Analytics App to Empower All

Zsenia, an investment research and analytics technology platform company based in New York, has officially launched their app in the Apple App Store. Founded and developed by Vikram Khullar, Reaz Islam, and Kevin Breen, a highly experienced team of investment, analytics, and technology development leaders, Zsenia's purpose is to offer everyone investment, research, and analytics data at an affordable price. It eliminates the need for multiple tools and data sources to help validate key information and separate it from all the noise and bombardment of data and news across various channels into one seamless application for investors. Read all the latest news.

The founders have over 100 years of combined investment experience over multiple business cycles (boom & busts), and want others to benefit from their experience and give them access to the tools they used to navigate through markets, both up and down. The founders, reflecting on their first-hand experience including Portfolio Management, Research, Risk Management and the need for Financial Advisors, selected the most relevant tools from their respective areas of expertise, to cut through all the information overload, into a unique product - Zsenia.

"Our mission is to democratize access to financial data and analytics for all," said George Stock, COO of Zsenia. "Only the privileged, such as institutional money managers, had access to data and analytics of such quality, but now Zsenia is available to everyone to get an edge. We have the users' best interests in mind, and Zsenia is created from the ground up, to empower users to make informed decisions."

Zsenia offers paying users in-depth analytics on stocks, ETFs and customized portfolios, including backtesting, portfolio optimization, and stress testing portfolios. It also offers completely free access to tools such as Financial Planning/Simulator, Premium News, Extensive Market and Economic Overview, Quotes and Comparisons, unlimited Equity and ETF Research, and a Prediction Tracker to help anyone get started and build confidence in their investments decisions. Founders will also randomly select registered users and provide direct training for free to get anyone started or improve their investment knowledge regardless of background and experience.

"Knowledge is power, but you still need a tool for validation and a reality check if you intend to beat the market more consistently," said Reaz Islam, co-founder of Zsenia. "Registered users can test drive all the features (Backtest, Optimize, Stress Testing/Simulation and more). The platform can help anyone interested in investing in the liquid markets across three dimensions, such as Security Selection, Asset Allocation and Market Timing. Whether the user is researching a stock or ETF to add to their portfolio (security selection), unsure about asset allocation, or just worried about the market and want to change your positions (market timing), we've got them covered."

Click here to read the latest news.:

https://jessicapressreleases.blogspot.com/2018/05/canine-camp-getaway-of-ny-dog-vacation.html

"Zsenia has a professional touch and feel, with access to proprietary sophisticated tools with proven applications, and developed for users from a wide range of backgrounds," said Kevin Breen, co-founder of Zsenia. "Zsenia bridges the gap between an investment concept and backs it up with solid empirical data and analytical validation."

Zsenia is an in-depth research and decision-making power tool utilizing proprietary technology that can help anyone get an edge, improve their investment performance and make better informed and smarter investments, "on the go".

A self-funded, simplified, investment, research, and analytics tool,Zsenia, is a user focused and an independent provider, not affiliated with any financial services platforms. It operates from New York and is registered as a corporation in Delaware.

Continue reading.:

https://jessicapressreleases.blogspot.com/2018/05/shmoop-prepares-students-for-ap-season.html

For more information including Founders Profile and Zsenia Academy please visit http://www.zsenia.com

Celmatix Welcomes Fertility Specialists Medical Group to the Personalized Reproductive Medicine Initiative

Today, Celmatix, the next-generation women's health company, announced the addition of Fertility Specialists Medical Group to the Personalized Reproductive Medicine Initiative (PReM). Comprising the premiere academic and private fertility treatment centers across the United States, PReM members are united by a common goal to leverage big data and genomics to better understand the reproductive challenges faced by millions of people around the world.

Fertility Specialists Medical Group represents one of the region's most highly regarded fertility clinics, having been named to San Diego Magazine's "Top Doctors" list for five years in a row. With two locations in San Diego and Carlsbad, California, they help patients achieve their reproductive goals by delivering comprehensive, advanced fertility care in a supportive, welcoming, and efficient environment.

"We're excited to welcome Fertility Specialists Medical Group into the PReM Initiative," said Piraye Yurttas Beim, PhD, Founder and CEO of Celmatix. "Diversity is important when building foundational datasets like the one undertaken by the PReM Initiative. The addition of FSMG expands the geographical footprint of our initiative to Southern California, but also expands the diversity of individuals and unique fertility journeys represented in our research discoveries. Dr. Morales has an impressive track record with cutting edge research in our field, and we feel privileged to be partnered with her and the talented physicians on her team."

"It's an honor to be a part of this coordinated, diverse group of organizations committed to exploring genomics in women's healthcare across the nation," said Arlene J. Morales, M.D., Medical Director and Founder, Fertility Specialists Medical Group. "Infertility is such a pervasive and physically and emotionally burdensome disease state. It's important that we advance the field to look beyond individuals' symptoms to start finding new ways to help people plan their families."

Insights from the PReM initiative have the potential to revolutionize how fertility difficulties are diagnosed, treated, and possibly prevented. For additional information on the PReM initiative, please visit http://www.celmatix.com/prem. If you or your colleagues would like to join the PReM Initiative, please contact prem(at)celmatix(dot)com.

About Celmatix Inc.

Celmatix is a next-generation women's health company transforming reproductive health care through genomics and big data. Founded in 2009 and based in New York City, Celmatix is disrupting how women approach their lifelong fertility journey by empowering them and their physicians with more personalized information. The company's research-driven products include the Fertilome® test, the world's first multigene panel test that reveals what a woman's DNA says about her reproductive health, Polaris®, a real-time predictive analytics platform in use at leading fertility clinics across the U.S., which helps physicians optimize patient outcomes and improve the patient experience, and MyFertility Compass™, a data-driven education tool that gives women who are currently trying to conceive insights into their fertility potential. Read all the latest news.

The Good Citizen Network is Using Blockchain Technology to Guarantee Honest Donations

The Good Citizen Network (GCN), a social platform that provides volunteers, nonprofits, donors, and organizations with a safe way to transfer donations and services between one another, is demonstrating the powerful transparency and reliability that comes from building atop blockchain technology.

Read all the latest news.:

https://jessicapressreleases.blogspot.com/2018/05/rob-lowe-hosts-new-on-demand-segment-on.html

Hailed as a revolutionary development, introducing a public ledger system that makes hacking near impossible, blockchain is removing all middlemen from the equation, thereby making everything more trustworthy.

"As much as 90% of donations online today are not diverted to their original intent," said Katherine Chen, Founder of the GCN. "Due to this untrustworthiness, more and more people are shying away from volunteering and donating. With blockchain technology, a public ledger system makes everything open and accessible, using distributed ledger technology that is immutable. People can finally trust their donations again."

When donors donate with the GCN, they can see where their donation goes publicly, without worrying about pocketing of the money. Since they can now measure their positive impact, they will receive a personal satisfaction that encourages more volunteering and giving back in the future. Continue reading.

Driving accountability in charitable giving, which holds the organizations and charities responsible for doing the right thing as well, the "do good movement" will catch on worldwide. Using the GCN to find their support base, it's going to bring together two parties of people that can make all global communities a better place (see Donation Component in GCN whitepaper).

"Officially available today, we are accepting any individual, nonprofit, and charitable organization that wants to get in on the future of donating," said Chen. "Encourage your favorite charity to take part and receive a public level of trustworthiness they never thought was possible."

It is free to download the join the GCN at this time.

For more information, visit: https://www.goodcitizen.network/

VetStem Biopharma CEO, Dr. Robert Harman, will Present Data on Stem Cells for Kidney Disease in Poster Session at Feline Veterinary Conference

Leading regenerative veterinary medicine company, VetStem Biopharma, will be exhibiting at the American Association of Feline Practitioners Conference (AAFP) later this month. The company's CEO and founder, Dr. Robert Harman, will be presenting data on adipose-derived stem cell therapy for the treatment of chronic kidney disease in felines at a poster session on Saturday, September 29th. The conference is being held in Charlotte, North Carolina September 27-30, 2018. Read this for more information.

At the poster session, Dr. Harman will be presenting and answering questions regarding outcome data collected on 40 clinical cases of chronic kidney disease (CKD) in cats that were treated with adipose-derived stem cell therapy. The authors hypothesized that stem cell therapy could improve the clinical course of CKD. Though informal and unblinded, the study concluded that stem cell therapy may provide clinical benefit and be a low-risk treatment option for cats with chronic CKD.

Additional controlled studies are necessary to further evaluate the benefit of adipose-derived stem cell therapy in CKD however these initial results are promising as recent reviews suggest that CKD may be the number one cause of mortality in older felines. While VetStem's autologous (patient-derived) stem cell service is available to veterinarians in the United States and Canada, the company has plans to work with the FDA to develop an off-the-shelf donor-derived stem cell product for use in feline disease therapy. Currently, the company has three Investigational New Animal Drug applications filed with the FDA.

As the first company to provide adipose-derived stem cell services to veterinarians across the United States and Canada, VetStem Biopharma is considered a leader in the industry of regenerative veterinary medicine. Over 14,000 animals have been treated utilizing the company's autologous stem cell service. Dr. Harman has been a trailblazer in the field of regenerative medicine for over a decade and presents at both human and animal medical conferences around the world. He most recently spoke in Sacramento at the 2018 North American Veterinary Regenerative Medicine Association Conference. He applies his biotechnology and veterinary experience in the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. Dr. Harman has also authored 14 peer-reviewed articles and book chapters.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients' own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 16 years and 14,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.

Wednesday, September 12, 2018

Tuesday, September 11, 2018

Click here to read the latest news.:

Continue reading.:

Read all the latest news.:

Related News: